Canada markets closed

Mayne Pharma Group Limited (HG6.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.2600-0.0400 (-0.93%)
At close: 08:10AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 366.07M
Enterprise Value 293.49M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.12
Price/Book (mrq)1.08
Enterprise Value/Revenue 0.39
Enterprise Value/EBITDA -0.61

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 390.18%
S&P500 52-Week Change 326.27%
52 Week High 34.4400
52 Week Low 31.6300
50-Day Moving Average 34.2024
200-Day Moving Average 33.1469

Share Statistics

Avg Vol (3 month) 312
Avg Vol (10 day) 3N/A
Shares Outstanding 585.07M
Implied Shares Outstanding 685.93M
Float 857.4M
% Held by Insiders 124.96%
% Held by Institutions 117.57%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jan 18, 2023
Last Split Factor 21:20
Last Split Date 3Jan 18, 2023

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -76.21%
Operating Margin (ttm)-20.19%

Management Effectiveness

Return on Assets (ttm)-5.46%
Return on Equity (ttm)-40.74%

Income Statement

Revenue (ttm)319.28M
Revenue Per Share (ttm)3.93
Quarterly Revenue Growth (yoy)259.80%
Gross Profit (ttm)N/A
EBITDA -46.2M
Net Income Avi to Common (ttm)-274.18M
Diluted EPS (ttm)-1.9500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)154.81M
Total Cash Per Share (mrq)1.9
Total Debt (mrq)36.58M
Total Debt/Equity (mrq)6.68%
Current Ratio (mrq)1.61
Book Value Per Share (mrq)6.74

Cash Flow Statement

Operating Cash Flow (ttm)-14.62M
Levered Free Cash Flow (ttm)46.43M